The Valley Desk

NCT04429321 · Interventional trial

Nivolumab + Ipilimumab With Immunostimulatory Embolization for Stage 4 Renal Cell Carcinoma With Unresected Primary

Overall registry status Terminated

Phase 1

Conditions Renal Cell Carcinoma, Renal Cell Carcinoma Stage IV

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov